Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inositol for CRP reduction and pregnancy rate in women with PCOS
IRCT20230522058253N6Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bCalm in polycystic ovary syndrome (PCOS), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Change in C-reactive protein (CRP) level and Pregnancy rate. Started Apr 2025; status: completed.
02
Drugs
bCalm
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20230522058253N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058253N6.